Compare, Analyse Torrent Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TORRENT PHARMA     Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-19
TEVA PHARMA
Dec-13
TORRENT PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,9643,072-   
Low Rs1,2452,668-   
Sales per share (Unadj.) Rs453.41,762.9-  
Earnings per share (Unadj.) Rs25.8110.1-  
Cash flow per share (Unadj.) Rs62.3252.6-  
Dividends per share (Unadj.) Rs17.0096.40-  
Dividend yield (eoy) %1.13.4 31.5%  
Book value per share (Unadj.) Rs279.21,958.2-  
Shares outstanding (eoy) m169.22848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.51.6 217.4%   
Avg P/E ratio x62.226.1 238.8%  
P/CF ratio (eoy) x25.811.4 226.7%  
Price / Book Value ratio x5.71.5 392.1%  
Dividend payout %65.987.5 75.3%   
Avg Mkt Cap Rs m271,5132,433,768 11.2%   
No. of employees `00013.644.9 30.3%   
Total wages/salary Rs m14,0380-   
Avg. sales/employee Rs Th5,642.633,260.8 17.0%   
Avg. wages/employee Rs Th1,032.40-   
Avg. net profit/employee Rs Th320.92,077.8 15.4%   
INCOME DATA
Net Sales Rs m76,7281,494,907 5.1%  
Other income Rs m5710-   
Total revenues Rs m77,2991,494,907 5.2%   
Gross profit Rs m19,831409,381 4.8%  
Depreciation Rs m6,177120,835 5.1%   
Interest Rs m5,03829,362 17.2%   
Profit before tax Rs m9,187259,184 3.5%   
Minority Interest Rs m01,177 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,570-170,140 2.1%   
Tax Rs m1,254-3,164 -39.6%   
Profit after tax Rs m4,36393,386 4.7%  
Gross profit margin %25.827.4 94.4%  
Effective tax rate %13.6-1.2 -1,117.6%   
Net profit margin %5.76.2 91.0%  
BALANCE SHEET DATA
Current assets Rs m50,3751,009,655 5.0%   
Current liabilities Rs m51,653880,504 5.9%   
Net working cap to sales %-1.78.6 -19.3%  
Current ratio x1.01.1 85.1%  
Inventory Days Days9291 101.4%  
Debtors Days Days6896 71.2%  
Net fixed assets Rs m83,648488,270 17.1%   
Share capital Rs m8463,680 23.0%   
"Free" reserves Rs m46,3970-   
Net worth Rs m47,2441,660,558 2.8%   
Long term debt Rs m39,129764,379 5.1%   
Total assets Rs m141,2093,416,342 4.1%  
Interest coverage x2.89.8 28.7%   
Debt to equity ratio x0.80.5 179.9%  
Sales to assets ratio x0.50.4 124.2%   
Return on assets %6.73.6 185.3%  
Return on equity %9.25.6 164.2%  
Return on capital %12.34.9 250.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m16,5810-   
CASH FLOW
From Operations Rs m17,981238,211 7.5%  
From Investments Rs m-2,413-84,408 2.9%  
From Financial Activity Rs m-13,145-285,750 4.6%  
Net Cashflow Rs m2,380-131,947 -1.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 73.59 Rs / USD

Compare TORRENT PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare TORRENT PHARMA With: GSK PHARMA  FRESENIUS KABI ONCO.  ALKEM LABORATORIES  FDC  LUPIN  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views On News

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

TORRENT PHARMA SHARE PRICE


May 12, 2021 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS